138 related articles for article (PubMed ID: 25364428)
1. Distinct allelic expression patterns of imprinted
Ozaki S; Kawahara E; Maenaka S; Hoang NV; Oyama T; Imai M; Oda M; Yano S
Oncol Lett; 2014 Dec; 8(6):2561-2564. PubMed ID: 25364428
[TBL] [Abstract][Full Text] [Related]
2. Loss of imprinting in IGF2 in colorectal carcinoma assessed by microdissection.
Maenaka S; Hikichi T; Imai MA; Minamoto T; Kawahara E
Oncol Rep; 2006 Apr; 15(4):791-5. PubMed ID: 16525660
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of primary lung cancer in the central China region.
Zhang M; Wu CH; Zhu XL; Wang YJ
Asian Pac J Cancer Prev; 2014; 15(18):7799-803. PubMed ID: 25292066
[TBL] [Abstract][Full Text] [Related]
4. H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway.
Gao T; He B; Pan Y; Gu L; Chen L; Nie Z; Xu Y; Li R; Wang S
Clin Transl Oncol; 2014 Apr; 16(4):410-7. PubMed ID: 23943562
[TBL] [Abstract][Full Text] [Related]
5. IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma.
Murata A; Baba Y; Watanabe M; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Morita M; Nakao M; Baba H
Ann Surg Oncol; 2014 Apr; 21(4):1166-74. PubMed ID: 24318096
[TBL] [Abstract][Full Text] [Related]
6. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
[TBL] [Abstract][Full Text] [Related]
7. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR.
Xu W; Fan H; He X; Zhang J; Xie W
J Exp Clin Cancer Res; 2006 Dec; 25(4):543-7. PubMed ID: 17310846
[TBL] [Abstract][Full Text] [Related]
8. [The aberrant imprinting of insulin-like growth factor II and H19 in human hepatocellular carcinoma].
Wu J; Qin Y; Li B; He WZ; Sun ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):49-52. PubMed ID: 17294726
[TBL] [Abstract][Full Text] [Related]
9. Loss of imprinting of the insulin-like growth factor 2 and the H19 gene in testicular seminomas detected by real-time PCR approach.
Stier S; Neuhaus T; Albers P; Wernert N; Grünewald E; Forkert R; Vetter H; Ko Y
Arch Toxicol; 2006 Oct; 80(10):713-8. PubMed ID: 16721595
[TBL] [Abstract][Full Text] [Related]
10. Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues.
Zhao R; DeCoteau JF; Geyer CR; Gao M; Cui H; Casson AG
Carcinogenesis; 2009 Dec; 30(12):2117-22. PubMed ID: 19843644
[TBL] [Abstract][Full Text] [Related]
11. Loss of genomic imprinting of insulin-like growth factor 2 is strongly associated with cellular proliferation in normal hematopoietic cells.
Hofmann WK; Takeuchi S; Frantzen MA; Hoelzer D; Koeffler HP
Exp Hematol; 2002 Apr; 30(4):318-23. PubMed ID: 11937266
[TBL] [Abstract][Full Text] [Related]
12. Loss of imprinting and overexpression of IGF2 gene in gastric adenocarcinoma.
Wu MS; Wang HP; Lin CC; Sheu JC; Shun CT; Lee WJ; Lin JT
Cancer Lett; 1997 Nov; 120(1):9-14. PubMed ID: 9570380
[TBL] [Abstract][Full Text] [Related]
13. Genomic imprinting of H19 and insulin-like growth factor-2 in pediatric germ cell tumors.
Ross JA; Schmidt PT; Perentesis JP; Davies SM
Cancer; 1999 Mar; 85(6):1389-94. PubMed ID: 10189147
[TBL] [Abstract][Full Text] [Related]
14. Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene.
Cruz-Correa M; Zhao R; Oviedo M; Bernabe RD; Lacourt M; Cardona A; Lopez-Enriquez R; Wexner S; Cuffari C; Hylind L; Platz E; Cui H; Feinberg AP; Giardiello FM
Epigenetics; 2009 Feb; 4(2):114-8. PubMed ID: 19242102
[TBL] [Abstract][Full Text] [Related]
15. [Loss of imprinting of IGF2 in cord blood of newborns of Chinese Han population].
Dai YM; Hu YL; Wang ZQ; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):10-4. PubMed ID: 17285535
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-2 (IGF2) loss of imprinting marks a field defect within human prostates containing cancer.
Bhusari S; Yang B; Kueck J; Huang W; Jarrard DF
Prostate; 2011 Nov; 71(15):1621-30. PubMed ID: 21432864
[TBL] [Abstract][Full Text] [Related]
17. Altered imprinting, promoter usage, and expression of insulin-like growth factor-II gene in gestational trophoblastic diseases.
Kim SJ; Park SE; Lee C; Lee SY; Kim IH; An HJ; Oh YK
Gynecol Oncol; 2003 Mar; 88(3):411-8. PubMed ID: 12648595
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer.
Zuo QS; Yan R; Feng DX; Zhao R; Chen C; Jiang YM; Cruz-Correa M; Casson AG; Kang XD; Han F; Chen T
Mol Carcinog; 2011 May; 50(5):390-6. PubMed ID: 21268128
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of IGF2 imprinting status and the levels of folate biomarkers in second trimester pregnant Chinese women.
Gao RF; He JL; Liu XQ; Ding YB; Chen XM; Chen Q; Tan Y; Wang YX
J Reprod Med; 2011; 56(5-6):254-60. PubMed ID: 21682122
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors.
Bjornsson HT; Brown LJ; Fallin MD; Rongione MA; Bibikova M; Wickham E; Fan JB; Feinberg AP
J Natl Cancer Inst; 2007 Aug; 99(16):1270-3. PubMed ID: 17686827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]